In 2021, TB Global Technologies Ltd. (TBG) was established through the merger of Tokyo Boeki Machinery Ltd. and Tokyo Boeki Engineering Ltd. that was formerly known as Niigata loading systems ltd. and Niigata Engineering ltd. We have been creating new values by gathering the strengths we have...
explore new products and technologies need more information? visit faqs don't show this again a note to our customers western digital has separated into two independent companies and the support process for your western digital and sandisk brand hdd and flash products may have changed. to continue...
信息 提供者 ZMQ Technologies Pvt. Ltd. 大小 7.7 MB 类別 教育 兼容性 iPhone 设备需装有 iOS 9.0 或更高版本。 iPad 设备需装有 iPadOS 9.0 或更高版本。 iPod touch 设备需装有 iOS 9.0 或更高版本。 Mac 需要macOS 11.0 或更高版本以及装有 Apple M1 或更高版本芯片的 Mac。
Wilson, Paul
[更多]Vishay Intertechnologies Wirewound Resistors - SMD 1ohms 1/2watt .5% RoHS: Not compliant 搜索 TB22500001 [更多]TXC Corporation Standard Clock Oscillators 22.5792MHz 1.8V -40C +85C RoHS: Compliant 搜索 美国3号仓库仓库直销,订单金额100元起订,满300元含运,满500元含税运,有单就有优惠,量大...
The global tuberculosis (TB) diagnostics market size was valued at USD 2.17 billion in 2023 and is projected to grow from USD 2.28 billion in 2024 to USD 3.58 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period (2024-2032). North America dominated the tuberculosis ...
The Global Good Fund, a collaboration between Intellectual Ventures (IV) and Bill Gates to develop technologies for humanitarian impact, aims to address this gap by developing an easy-to-use and affordable early tuberculosis diagnostic device for countries with limited healthcare infrastructure. To cre...
-- May 20, 2021 –Credo, a global innovation leader in advanced connectivity solutions delivering high performance, low power connectivity solutions for 100G, 400G, and 800G port-enabled networks, today announced the production availability of Nutcracker, the industry's first low-power 3.2Tbps ...
As a part of global efforts to control tuberculosis through effective DOTS implementation, the World Health Organization has recently begun addressing the issue of private providers in TB control through an evolving global strategy. As a first step, a global assessment of private providers’ ...
Technologies based on microfluidic devices, extensively used in diagnostic testing [66], [67], likely provide innovative solutions applicable to TB [68]. Future development of these novel tools will overcome geographic, economic and resource limitations as part of the WHO End TB strategy [69]. 3...